Article
Fitness profiling links topoisomerase II regulation of centromeric integrity to doxorubicin resistance in fission yeast.
Scientific reports - 11 Feb 2015
Nguyen Thi Thuy Trang, Lim Julia Sze Lynn, Tang Richard Ming Yi, Zhang Louxin, Chen Ee Sin
Abstract excerpt
Doxorubicin, a chemotherapeutic agent, inhibits the religation step of topoisomerase II (Top2). However, the downstream ramifications of this action are unknown. Here we performed epistasis analyses of top2 with 63 genes representing doxorubicin resistance (DXR) genes in fission yeast and revealed a subset that synergistically collaborate with Top2 to confer DXR. Our findings show that the chromatin-regulating...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
